James E. Francese - 21 Mar 2022 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Sr. VP, Comm. Ops., NA, APAC
Issuer ticker: STAA
Reported as of: 21 Mar 2022
Net transaction value: -$68,800
SEC form: 4
Accepted by SEC: 23 Mar 2022, 16:24:55 UTC
Prior SEC filing: 16 Mar 2022
Next SEC filing: 29 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Samuel Gesten as attorney-in-fact for James Francese

Key filing fact

James E. Francese filed Form 4 for STAAR SURGICAL CO (STAA) on 23 Mar 2022.

Key facts

This page summarizes James E. Francese's Form 4 filing for STAAR SURGICAL CO (STAA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Mar 2022, 16:24.

Change

Previous filing in this sequence was filed on 16 Mar 2022.
Current net transaction value: -$68,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STAA transaction

Common Stock

Sale

Transaction value: $68,800
Shares: -922
Change %: -1.6%
Price: $74.62
Shares after: 57,258
Date: 21 Mar 2022
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This Form 4 reflects the sale by Mr. Francese of currently held Common Stock of the Company pursuant to 'sell to cover taxes' instructions contained in a pre-established Rule 10b5-1 plan (relating to restricted stock units that vested on March 20,2022).